MORE►
Kathleen Otto-Rosenblum
Kathleen Otto-Rosenblum, CEO of BioNTX [Photo: BioNTX]
The Last Word: How Advanced Therapies Week 2025 Positioned Dallas as a Life Sciences Leader
by David Seeley | Feb 12, 2025
Advanced Therapies Week 2025—a conference focused on the latest innovations in cell and gene therapies, regenerative medicine, and other biotechnologies—attracted industry leaders, researchers, and visionaries to Dallas' Kay Bailey Hutchison Convention Center in late January. Organized by London-based Phacilitate, the 4-day conference acted as a "collaborative hub" showcasing the intersection of cutting-edge science, transformative healthcare solutions, and dynamic regional collaboration.
by Lance Murray |
Jun 17, 2024
The 2024 iC3 Summit, hosted by nonprofit BioNTX, is set to welcome over 1,000 industry professionals, researchers, entrepreneurs, and investors for its largest gathering yet. The event's formula—Innovation = Capital × Collaboration × Commercialization,—underscores its mission to drive breakthroughs through strategic partnerships and investments.
The 2024 iC3 Summit, hosted by nonprofit BioNTX, is set to welcome over 1,000 industry professionals, researchers, entrepreneurs, and investors for its largest gathering yet. The event's formula—Innovation = Capital × Collaboration × Commercialization—underscores its mission to drive breakthroughs through strategic partnerships and investments.
MORE►
